CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Delcath Systems, Inc. - DCTH CFD

    2.74
    3.86%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.04
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 2.85
    Open* 2.81
    1-Year Change* -3.77%
    Day's Range* 2.72 - 2.85
    52 wk Range 2.25-7.99
    Average Volume (10 days) 668.87K
    Average Volume (3 months) 8.67M
    Market Cap 65.26M
    P/E Ratio -100.00K
    Shares Outstanding 22.05M
    Revenue 2.17M
    EPS -3.52
    Dividend (Yield %) N/A
    Beta 0.51
    Next Earnings Date Mar 25, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 1, 2023 2.85 0.15 5.56% 2.70 2.88 2.68
    Nov 30, 2023 2.72 -0.04 -1.45% 2.76 2.88 2.70
    Nov 29, 2023 2.78 -0.08 -2.80% 2.86 2.91 2.78
    Nov 28, 2023 2.83 -0.14 -4.71% 2.97 2.97 2.79
    Nov 27, 2023 2.96 0.02 0.68% 2.94 3.10 2.93
    Nov 24, 2023 2.98 0.11 3.83% 2.87 2.99 2.84
    Nov 22, 2023 2.88 -0.11 -3.68% 2.99 3.07 2.85
    Nov 21, 2023 2.95 0.03 1.03% 2.92 3.03 2.71
    Nov 20, 2023 2.67 0.19 7.66% 2.48 2.83 2.44
    Nov 17, 2023 2.42 -0.05 -2.02% 2.47 2.52 2.36
    Nov 16, 2023 2.46 0.10 4.24% 2.36 2.50 2.35
    Nov 15, 2023 2.37 0.08 3.49% 2.29 2.59 2.29
    Nov 14, 2023 2.30 -0.60 -20.69% 2.90 2.95 2.30
    Nov 13, 2023 2.96 0.09 3.14% 2.87 3.03 2.87
    Nov 10, 2023 2.93 -0.01 -0.34% 2.94 3.00 2.86
    Nov 9, 2023 2.97 -0.13 -4.19% 3.10 3.12 2.89
    Nov 8, 2023 3.13 -0.07 -2.19% 3.20 3.25 3.10
    Nov 7, 2023 3.22 0.03 0.94% 3.19 3.27 3.10
    Nov 6, 2023 3.17 0.10 3.26% 3.07 3.25 3.07
    Nov 3, 2023 3.11 -0.09 -2.81% 3.20 3.30 3.01

    Delcath Systems, Inc. Events

    Time (UTC) Country Event
    Monday, March 25, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q4 2023 Delcath Systems Inc Earnings Release
    Q4 2023 Delcath Systems Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 2.719 3.555 1.646 1.58 3.407
    Revenue 2.719 3.555 1.646 1.58 3.407
    Cost of Revenue, Total 0.686 0.671 0.64 0.719 1.009
    Gross Profit 2.033 2.884 1.006 0.861 2.398
    Total Operating Expense 36.572 28.086 22.949 21.488 31.601
    Selling/General/Admin. Expenses, Total 16.103 13.637 11.108 11.279 9.819
    Research & Development 18.583 13.778 11.201 9.49 19.65
    Operating Income -33.853 -24.531 -21.303 -19.908 -28.194
    Interest Income (Expense), Net Non-Operating -2.685 -1.186 -3.007 11.027 8.921
    Other, Net 0.03 0.068 0.154 0.002 0.051
    Net Income Before Taxes -36.508 -25.649 -24.156 -8.879 -19.222
    Net Income After Taxes -36.508 -25.649 -24.156 -8.879 -19.222
    Net Income Before Extra. Items -36.508 -25.649 -24.156 -8.879 -19.222
    Net Income -36.508 -25.649 -24.156 -8.879 -19.222
    Total Adjustments to Net Income 0 -0.055 0
    Income Available to Common Excl. Extra. Items -36.508 -25.649 -24.211 -8.879 -19.222
    Income Available to Common Incl. Extra. Items -36.508 -25.649 -24.211 -8.879 -19.222
    Diluted Net Income -36.508 -25.649 -24.211 -8.879 -19.222
    Diluted Weighted Average Shares 8.86462 7.14575 2.89783 0.0259 0.03819
    Diluted EPS Excluding Extraordinary Items -4.1184 -3.5894 -8.35488 -342.819 -503.343
    Diluted Normalized EPS -3.98303 -3.5894 -8.35488 -342.819 -473.936
    Unusual Expense (Income) 1.2 0 1.123
    Total Extraordinary Items
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0.495 0.597 0.639 0.906 0.797
    Revenue 0.495 0.597 0.639 0.906 0.797
    Cost of Revenue, Total 0.15 0.181 0.237 0.235 0.18
    Gross Profit 0.345 0.416 0.402 0.671 0.617
    Total Operating Expense 8.492 8.922 10.165 8.707 10.283
    Selling/General/Admin. Expenses, Total 4.787 4.165 4.994 3.319 4.497
    Research & Development 3.555 4.576 4.934 3.953 5.606
    Operating Income -7.997 -8.325 -9.526 -7.801 -9.486
    Interest Income (Expense), Net Non-Operating 0.789 -0.688 -0.645 -0.73 -0.665
    Other, Net 0.006 0.013 0.028 0.026 -0.008
    Net Income Before Taxes -7.202 -9 -10.143 -8.505 -10.159
    Net Income After Taxes -7.202 -9 -10.143 -8.505 -10.159
    Net Income Before Extra. Items -7.202 -9 -10.143 -8.505 -10.159
    Net Income -7.202 -9 -10.143 -8.505 -10.159
    Income Available to Common Excl. Extra. Items -7.202 -9 -10.143 -8.505 -10.159
    Income Available to Common Incl. Extra. Items -7.202 -9 -10.143 -8.505 -10.159
    Diluted Net Income -7.202 -9 -10.143 -8.505 -10.159
    Diluted Weighted Average Shares 12.4637 11.6224 9.85044 9.21579 8.19048
    Diluted EPS Excluding Extraordinary Items -0.57784 -0.77437 -1.0297 -0.92287 -1.24034
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.57784 -0.77437 -1.0297 -0.79266 -1.24034
    Total Adjustments to Net Income
    Unusual Expense (Income) 0 1.2
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 16.155 31.152 32.338 12.617 5.919
    Cash and Short Term Investments 7.671 22.802 28.575 10.002 2.516
    Cash & Equivalents 7.671 22.802 28.575 10.002 2.516
    Total Receivables, Net 0.366 0.044 0.057 0.021 1.164
    Accounts Receivable - Trade, Net 0.366 0.044 0.057 0.021 0.585
    Total Inventory 1.998 1.412 0.855 0.654 0.858
    Other Current Assets, Total 4.369 5.264 0.181 0.181 1.381
    Total Assets 17.862 33.124 34.635 14.212 6.844
    Property/Plant/Equipment, Total - Net 1.707 1.972 2.297 1.595 0.925
    Property/Plant/Equipment, Total - Gross 6.638 6.797 5.232
    Accumulated Depreciation, Total -4.931 -4.825 -4.307
    Total Current Liabilities 14.735 5.954 10.035 15.994 17.75
    Accounts Payable 2.018 0.638 1.774 4.533 7.715
    Accrued Expenses 4.871 3.974 5.736 7.611 3.434
    Notes Payable/Short Term Debt 0 0.551 0 0 0
    Current Port. of LT Debt/Capital Leases 7.846 0.621 2 0 2.038
    Other Current Liabilities, Total 0 0.17 0.525 3.85 4.563
    Total Liabilities 23.721 21.172 12.557 20.569 21.783
    Total Long Term Debt 7.842 15.011 0 2 0
    Other Liabilities, Total 1.144 0.207 2.522 2.575 4.033
    Total Equity -5.859 11.952 22.078 -6.357 -14.939
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.1 0.079 0.06 0.001 0.103
    Additional Paid-In Capital 451.608 432.831 417.449 364.785 328.962
    Retained Earnings (Accumulated Deficit) -457.484 -420.976 -395.327 -371.171 -344.054
    Treasury Stock - Common 0
    Other Equity, Total -0.083 0.018 -0.104 0.028 0.05
    Total Liabilities & Shareholders’ Equity 17.862 33.124 34.635 14.212 6.844
    Total Common Shares Outstanding 10.0466 7.90673 5.9961 0.06709 0.01463
    Prepaid Expenses 1.751 1.63 2.67 1.759
    Other Long Term Assets, Total 0
    Long Term Debt 7.842 15.011 0 2
    Total Preferred Shares Outstanding 0.01136 0.01136
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 46.096 19.472 29.022 16.155 18.48
    Cash and Short Term Investments 40.462 14.54 24.222 7.671 9.831
    Cash & Equivalents 40.462 14.54 24.222 7.671 9.831
    Total Receivables, Net 0.205 0.127 0.458 0.366 0.537
    Accounts Receivable - Trade, Net 0.205 0.127 0.458 0.366 0.537
    Total Inventory 2.667 2.48 2.337 1.998 1.926
    Prepaid Expenses 2.285 2.019 1.721 1.751 1.84
    Other Current Assets, Total 0.477 0.306 0.284 4.369 4.346
    Total Assets 47.577 21.05 30.599 17.862 20.226
    Property/Plant/Equipment, Total - Net 1.481 1.578 1.577 1.707 1.746
    Property/Plant/Equipment, Total - Gross 6.498 6.577 6.547 6.638 6.609
    Accumulated Depreciation, Total -5.017 -4.999 -4.97 -4.931 -4.863
    Total Current Liabilities 13.974 11.114 13.411 14.735 14.446
    Accounts Payable 0.753 0.966 2.428 2.018 2.632
    Accrued Expenses 5.265 5.638 7.213 4.871 5.333
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 7.956 4.51 3.77 7.846 6.481
    Other Current Liabilities, Total 0 0
    Total Liabilities 22.858 21.292 25.307 23.721 25.472
    Total Long Term Debt 2 5.252 5.798 7.842 9.727
    Other Liabilities, Total 6.884 4.926 6.098 1.144 1.299
    Total Equity 24.719 -0.242 5.292 -5.859 -5.246
    Common Stock 0.197 0.153 0.101 0.1 0.086
    Additional Paid-In Capital 518.607 473.355 453.37 451.608 442.066
    Retained Earnings (Accumulated Deficit) -494.026 -473.686 -466.483 -457.484 -447.341
    Other Equity, Total -0.059 -0.064 -0.064 -0.083 -0.057
    Total Liabilities & Shareholders’ Equity 47.577 21.05 30.599 17.862 20.226
    Total Common Shares Outstanding 19.689 15.2505 10.0816 10.0466 8.59768
    Long Term Debt 2 5.252 5.798 7.842 9.727
    Preferred Stock - Non Redeemable, Net 0 0 18.368 0 0
    Total Preferred Shares Outstanding 0.03779 0.02098 0.01136 0.01136 0.01136
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -36.508 -25.649 -24.156 -8.879 -19.222
    Cash From Operating Activities -24.95 -22.604 -22.868 -23.69 -14.732
    Cash From Operating Activities 0.132 0.146 0.167 0.212 0.444
    Non-Cash Items 9.312 8.663 6.927 -7.92 -7.726
    Changes in Working Capital 2.114 -5.764 -5.806 -7.103 11.772
    Cash From Investing Activities -0.209 -0.143 -0.782 -0.024 -0.076
    Capital Expenditures -0.209 -0.143 -0.782 -0.024 -0.076
    Other Investing Cash Flow Items, Total
    Cash From Financing Activities 10.143 20.822 42.355 30.305 13.236
    Financing Cash Flow Items 0 -0.107 26.475 0
    Issuance (Retirement) of Stock, Net 10.857 6.385 42.488 0.15 12.442
    Issuance (Retirement) of Debt, Net -0.714 14.437 -0.026 3.68 0.794
    Foreign Exchange Effects -0.115 0.122 -0.132 0.014 -0.174
    Net Change in Cash -15.131 -1.803 18.573 6.605 -1.746
    Cash Interest Paid 1.873 0.681 0.011
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -9 -36.508 -26.365 -17.86 -8.203
    Cash From Operating Activities -4.264 -24.95 -17.591 -12.412 -6.375
    Cash From Operating Activities 0.03 0.132 0.098 0.031 0.031
    Non-Cash Items 1.982 9.312 5.378 3.785 1.805
    Cash Interest Paid 0.491 1.873 1.337 0.842 0.411
    Changes in Working Capital 2.724 2.114 3.298 1.632 -0.008
    Cash From Investing Activities 0 -0.209 -0.209 -0.141 -0.089
    Capital Expenditures 0 -0.209 -0.209 -0.141 -0.089
    Cash From Financing Activities 16.694 10.143 4.896 0 0
    Issuance (Retirement) of Stock, Net 23.007 10.857 4.896 0 0
    Issuance (Retirement) of Debt, Net -6.313 -0.714 0
    Foreign Exchange Effects 0.02 -0.115 -0.067 -0.046 0.002
    Net Change in Cash 12.45 -15.131 -12.971 -12.599 -6.462
    Financing Cash Flow Items
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Vivo Capital, LLC Venture Capital 7.7163 1178787 1178787 2023-06-30 LOW
    BVF Partners L.P. Hedge Fund 7.7163 1178787 1178787 2023-06-30 LOW
    Logos Global Management LLC Investment Advisor 7.7163 1178787 1178787 2023-06-30 HIGH
    Soleus Capital Management, L.P. Hedge Fund 5.2788 806420 806420 2023-08-15 HIGH
    Rosalind Advisors, Inc. Hedge Fund 3.0067 459315 59315 2022-12-21 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.545 388789 18463 2023-06-30 LOW
    Stonepine Capital Management, LLC Investment Advisor/Hedge Fund 2.4795 378787 378787 2023-06-30 HIGH
    Michel (Gerard J) Individual Investor 1.4947 228345 31110 2023-08-18 LOW
    Kent Lake Capital LLC Hedge Fund 1.4366 219468 0 2023-06-30 HIGH
    EAM Investors, LLC Investment Advisor/Hedge Fund 1.0165 155280 155280 2023-06-30 HIGH
    CIBC World Markets Inc. Research Firm 0.8164 124717 21885 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7628 116536 53803 2023-06-30 LOW
    Morgan Stanley Smith Barney LLC Investment Advisor 0.3988 60926 17115 2023-06-30 LOW
    Salamon (Steven A. J.) Individual Investor 0.3621 55315 0 2023-04-20 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2992 45703 30178 2023-06-30 LOW
    Purpura (John) Individual Investor 0.2718 41526 14505 2023-10-13 LOW
    Advisors Capital Management, LLC Investment Advisor 0.1769 27021 0 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1752 26757 0 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 0.1407 21500 9400 2023-06-30 HIGH
    Citadel Advisors LLC Hedge Fund 0.1203 18373 18373 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Delcath Systems, Inc. Company profile

    About Delcath Systems Inc

    Delcath Systems, Inc. is an oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company is a specialty pharmaceutical and medical device company developing its products. The Company's lead product candidate is HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Delcath Systems Inc revenues increased 27% to $1.4M. Net loss applicable to common stockholders increased 18% to $20.3M. Revenues reflect Product revenue increase of 35% to $1.1M, Other revenue increase of 9% to $392K. Higher net loss reflects Research and development expenses increase from $3M to $8.3M (expense), Stock-based Compensation in SGA increase from $49K to $4.2M (expense), Selling.

    Equity composition

    Common Stock $.01 Par, 12/10, 70M auth., 43,028,146 issd., less 28,100 shares in Treas. @ $51.1M. Insiders control 1.42%. InitialPublic Offering 10/20/00, 1.2M Units (1 Common+ 1Redeemable Warrant) @ $6 by Whale Securities Co . 5/20/03,Company sold 677,419 Units (5 Common + 5 Warrants) @ $3.10/unit. 98.3. 04/14, 1-for-16 Reverse stock split.

    Industry: Medical Prosthetics

    1633 Broadway Ste 22C
    NEW YORK
    NEW YORK 10019-6708
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,035.03 Price
    -1.780% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee 0.0118%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Oil - Crude

    73.34 Price
    -1.600% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee -0.0019%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    US100

    15,803.70 Price
    -1.150% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    XRP/USD

    0.62 Price
    -0.410% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading